Home > Healthcare > Medical Devices > Surgical Devices > Thrombectomy Devices Market

Thrombectomy Devices Market Share

Report ID: GMI5245
Published Date: Sep 2023
Report Format: PDF

Download Free Sample

Thrombectomy Devices Market Share

The competitive landscape of the thrombectomy devices market includes prominent companies, such as

Weigao Group (Argon Medical)
Lemaitre Vascular Inc.
Boston Scientific Corporation
Medtronic Plc.
Penumbra, Inc.
Edwards Lifesciences Corporation
Teleflex Incorporated
Stryker Corporation
Johnson & Johnson Services Inc.
Terumo Corporation

Authors: Mariam Faizullabhoy , Pratiksha Kamthe

Frequently Asked Questions (FAQ) :

Thrombectomy devices industry size was worth USD 1.4 billion in 2022 and is projected to record 7.3% CAGR from 2023 to 2032, owing to the rising prevalence of cardiovascular disorders worldwide.

Mechanical/fragmentation segment generated more than USD 425 million in revenue in 2022 and is poised to witness substantial growth at 7.1% CAGR from 2023-2032 owing to increasing usage to offer improved efficacy in the treatment of diseases.

North America thrombectomy devices market size is expected to witness 7.4% CAGR from 2023-2032 attributed to the growing awareness regarding vascular diseases among the population, the increase in healthcare expenditure, favorable reimbursement scenarios, and government initiatives.

Some prominent firms in the thrombectomy devices industry are Lemaitre Vascular Inc., Boston Scientific Corporation, Medtronic Plc., Penumbra, Inc., Edwards Lifesciences Corporation, Teleflex Incorporated, Stryker Corporation, Johnson & Johnson Services Inc., and Terumo Corporation.